BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20335019)

  • 1. The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.
    Lughezzani G; Karakiewicz PI; Bigot P; Perrotte P; Crépel M; Rioux-Leclercq N; Catros-Quemener V; Moulinoux JP; Bouet F; Cipolla B; Patard JJ
    Eur J Cancer; 2010 Jul; 46(10):1927-35. PubMed ID: 20335019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
    Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ
    J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited prognostic value of tumor necrosis in patients with renal cell carcinoma.
    Isbarn H; Patard JJ; Lughezzani G; Rioux-Leclercq N; Crépel M; Cindolo L; de la Taille A; Zini L; Villers A; Shariat SF; Bertini R; Karakiewicz PI
    Urology; 2010 Jun; 75(6):1378-84. PubMed ID: 19781745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of erythrocyte polyamines levels in renal cell carcinoma. Prospective study in 418 cases].
    Bigot P; Lughezzani G; Bensalah K; Rioux-Leclercq N; Guillé F; Lobel B; Moulinoux JP; Catros-Quemener V; Cipolla B; Azzouzi AR; Karakiewicz P; Patard JJ
    Prog Urol; 2010 Apr; 20(4):272-8. PubMed ID: 20380989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI; Hutterer GC; Trinh QD; Jeldres C; Perrotte P; Gallina A; Tostain J; Patard JJ
    Cancer; 2007 Sep; 110(6):1241-7. PubMed ID: 17639589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
    Capitanio U; Cloutier V; Zini L; Isbarn H; Jeldres C; Shariat SF; Perrotte P; Antebi E; Patard JJ; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Jun; 103(11):1496-500. PubMed ID: 19076149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
    Trinh QD; Schmitges J; Bianchi M; Sun M; Shariat SF; Sammon J; Jeldres C; Zorn K; Sukumar S; Perrotte P; Graefen M; Rogers CG; Peabody JO; Menon M; Karakiewicz PI
    BJU Int; 2012 Jul; 110(2 Pt 2):E21-7. PubMed ID: 22044638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival.
    Karakiewicz PI; Trinh QD; de la Taille A; Abbou CC; Salomon L; Tostain J; Cindolo L; Artibani W; Ficarra V; Patard JJ
    Eur J Cancer; 2007 Apr; 43(6):1023-9. PubMed ID: 17349784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
    Sengupta S; Lohse CM; Cheville JC; Leibovich BC; Thompson RH; Webster WS; Frank I; Zincke H; Blute ML; Kwon ED
    Cancer; 2006 Jan; 106(2):304-12. PubMed ID: 16353202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S; Kendel F; Spivak I; Pflanz S; Roigas J; Klotz T; May M
    BJU Int; 2009 May; 103(10):1375-80. PubMed ID: 19040527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality.
    Karakiewicz PI; Trinh QD; Lam JS; Tostain J; Pantuck AJ; Belldegrun AS; Patard JJ
    Eur Urol; 2007 Nov; 52(5):1428-36. PubMed ID: 17420085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
    Capitanio U; Jeldres C; Patard JJ; Perrotte P; Zini L; de La Taille A; Ficarra V; Cindolo L; Bensalah K; Artibani W; Tostain J; Valeri A; Zigeuner R; Méjean A; Descotes JL; Lechevallier E; Mulders PF; Lang H; Jacqmin D; Karakiewicz PI
    BJU Int; 2009 Jan; 103(1):33-7. PubMed ID: 18990161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
    J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.
    May M; Brookman-Amissah S; Roigas J; Gilfrich CP; Pflanz S; Hoschke B; Gunia S
    Urol Oncol; 2010; 28(3):274-9. PubMed ID: 18805709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.